Figure 5.
White blood cells counts in mice after packaging RNA (pRNA) nanoparticles injection. Clinical pathology analysis was conducted for the C57B/6 mice upon 1-week repeat intravenous (i.v.)-administrations of pRNA versus polyinosinic:polycytidylic acid (poly I:C) at the indicated doses. Total cell counts (left) and differentials (right) were displayed.